E COLI INFECTIONS

Clinical trials for E COLI INFECTIONS explained in plain language.

Never miss a new study

Get alerted when new E COLI INFECTIONS trials appear

Sign up with your email to follow new studies for E COLI INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug aims to shield vulnerable transplant patients from dangerous gut bacteria

Disease control Recruiting now

This study is testing a new oral drug, SNIPR001, in patients with blood cancers who are getting a stem cell transplant. The goal is to see if it can safely prevent dangerous, antibiotic-resistant E. coli infections in the gut when given alongside standard antibiotic prevention. R…

Matched conditions: E COLI INFECTIONS

Phase: PHASE1, PHASE2 • Sponsor: SNIPR Biome Aps. • Aim: Disease control

Last updated Apr 02, 2026 03:42 UTC

E COLI INFECTIONS

Get alerted when new E COLI INFECTIONS trials appear

New drug aims to shield vulnerable transplant patients from dangerous gut bacteria